Trial Information
Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain
Inclusion Criteria:
- Moderate to severe resting pain (scores above 5/10).
- Stable analgesic regimen.
- No surgical interventions planned during the study period.
- Able to self-assess pain and report it.
- Hospitalized or receiving home care for Stage I; out-patients or receiving home care
for Stage II.
- Wound not infected or covered with necrotic tissue.
Exclusion Criteria:
- True sensitivity to opioids
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Outcome Measure:
pain intensity reports
Principal Investigator
Pesach Shvartzman, Professor
Investigator Role:
Principal Investigator
Investigator Affiliation:
Ben-Gurion University of the Negev, Sial Research Center for Family Medicine and Primary Care
Authority:
Israel: Ministry of Health
Study ID:
SOR394105CTIL
NCT ID:
NCT00306020
Start Date:
January 2006
Completion Date:
June 2012
Related Keywords:
- Ulcer
- Wounds and Injuries
- Skin ulcers
- Topical morphine
- Chronic pain
- Cancer
- Ulcer
- Wounds and Injuries